Director at PROCEPT BioRobotics (PRCT) receives RSU and stock option grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PROCEPT BioRobotics Corp director Elisabeth Sandoval received new equity compensation awards. On June 9, 2026, she was granted 3,315 restricted stock units (RSUs), each representing one share of common stock, and stock options for 5,853 shares at an exercise price of $28.78 per share.
The RSUs and options vest in full on the earlier of the one-year anniversary of the grant date or the next annual meeting, subject to her continued service. After the RSU grant, Sandoval directly owns 15,876 shares of common stock. The newly granted options expire on June 8, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Little Elisabeth Sandoval
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,853 | $0.00 | -- |
| Grant/Award | Common Stock | 3,315 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,853 shares (Direct, null);
Common Stock — 15,876 shares (Direct, null)
Footnotes (1)
- These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Key Figures
RSUs granted: 3,315 shares
Stock options granted: 5,853 shares
Option exercise price: $28.78 per share
+3 more
6 metrics
RSUs granted
3,315 shares
Restricted stock units granted on June 9, 2026
Stock options granted
5,853 shares
Options on common stock granted on June 9, 2026
Option exercise price
$28.78 per share
Strike price for newly granted stock options
Shares owned after grant
15,876 shares
Common stock directly owned following RSU award
Option expiration date
June 8, 2036
Expiration for the 5,853-share stock option grant
Grant date
June 9, 2026
Date RSUs and stock options were awarded
Key Terms
restricted stock units (RSUs), Stock option, vest in full, annual meeting, +1 more
5 terms
restricted stock units (RSUs) financial
"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock option financial
"The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest in full financial
"The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting..."
annual meeting financial
"Vests in full on the earlier to occur of the one-year anniversary of the grant date, or the date of the next annual meeting following the grant date."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
exercise price financial
"The Stock option was granted on June 9, 2026, with an exercise price of 28.78 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transaction did PROCEPT BioRobotics (PRCT) report for Elisabeth Sandoval?
PROCEPT BioRobotics reported that director Elisabeth Sandoval received equity compensation awards. She was granted 3,315 restricted stock units and stock options for 5,853 shares, both vesting based on continued service and key future dates tied to the company’s annual meeting.
How many PROCEPT BioRobotics (PRCT) RSUs did Elisabeth Sandoval receive?
Elisabeth Sandoval received 3,315 restricted stock units from PROCEPT BioRobotics. Each RSU represents a contingent right to one share of common stock, vesting in full on the earlier of the one-year anniversary of the grant date or the next annual meeting, subject to continued service.
What are the terms of Elisabeth Sandoval’s new stock options at PROCEPT BioRobotics (PRCT)?
Sandoval was granted stock options for 5,853 shares of PROCEPT BioRobotics common stock at an exercise price of $28.78 per share. These options vest in full on the earlier of one year from grant or the next annual meeting, and expire on June 8, 2036.
When do Elisabeth Sandoval’s PROCEPT BioRobotics (PRCT) RSUs and options vest?
Both the RSUs and stock options vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the date of the next annual meeting, provided Sandoval continues in service through the applicable vesting date under the award terms.
Are Elisabeth Sandoval’s PROCEPT BioRobotics (PRCT) grants open-market purchases or compensation awards?
The transactions are compensation-related awards, not open-market purchases. The Form 4 uses code “A” for grant or award, covering 3,315 restricted stock units and options for 5,853 shares, both provided at no cash cost per share on the grant date.